Share

    


Home / Search Results

Search Results

You searched for:

Oncology Hematology Care, Inc. launched a one-year quality improvement project to implement and standardize comprehensive biomarker testing in patients with metastatic non-small cell lung cancer.
Learn how Dorcy Cancer Center at St Mary-Corwin Hospital in Pueblo, Colorado, developed and implemented the model tobacco cessation program.
This study at Atrium Health, Levine Cancer Institute, highlights the needs of patients with lung cancer and their care partners.
Key findings from an ACCC survey and education program.
This study examined the coping strategies and psychosocial well-being of patients with lung cancer facing multiple stressors, primarily due to the COVID-19 pandemic.
ACCC and AstraZeneca were recognized for their joint effort in the Rural Appalachian Lung Cancer Screening Initiative at the Cancer Moonshot: Goals Forum hosted, by the President and First Lady.
Cancer prevalence is increasing, and there is a gap between the growing number of patients and the number of oncology providers. Effective use of advanced practice providers (APPs) can help bridge this care gap.
The COVID-19 pandemic has had a negative impact in the rate of cancer screening across various states in the United States. Louisiana, Delaware, Kentucky and Northern Michigan serve as vehicles for an analysis of the disparity in cancer screening rates, before and after the pandemic.
The COVID-19 pandemic has created a necessity for the incorporation of remote home monitoring for cancer patients, in order to maintain the health of both the patient and the health care workers who aid them.
A mix-method approach to understand clinician use of biomarker testing for patients with non-small cell lung cancer.
An expert ACCC Steering Committee shares 32 informed treatment and care delivery recommendations for the ideal care of patients with non-small cell lung cancer.
This ACCC education program shares key highlights from a national survey of thoracic surgeons, radiation oncologists, and medical oncologists on the barriers that exist in the ideal management of patients with NSCLC.
There remains an overarching need to identify and provide guidance on key issues related to the optimal care of patients with NSCLC across different community cancer programs/settings in the U.S. To address this need, a multiphase project was implemented by ACCC and its partner organizations, with the main goal being to support the optimization of care for patients diagnosed with stage III and IV …
In this article, the authors discuss revisions to the Optimal Care Coordination Model following beta testing to develop the final version, rationale for significant revisions, and nationwide dissemination of the Model.